Alexander Lemaire, B.S.

Director, Process Development

Alexander Lemaire leads process development at Strand Therapeutics, shaping strategy and execution for mRNA and lipid nanoparticle manufacturing from concept to clinic. He builds scalable, phase-appropriate processes, defines control strategies, and steers tech transfer and external manufacturing partnerships. His work emphasizes platformization, throughput, and operational excellence—leveraging automation, digital tools, and design-of-experiments to compress timelines and reduce COGs while maintaining quality. Alexander collaborates across discovery, quality, regulatory, and supply to align roadmaps, de-risk programs, and deliver CMC packages that enable development milestones. Earlier in his career he supported analytical method development to ensure fit-for-purpose characterization and release—experience that informs his pragmatic approach to process design. He holds a B.S. in Biology.